Private healthcare provider Raffles Medical Group Ltd saw its shares fall recently. Over the past five days, Raffles Medical’s share price has tumbled 11 per cent to $1.39 at the time of writing. However, I think the recent selldown is an opportunity for long-term investors to consider having part-ownership in a company with huge potential for growth. Let’s explore more.
Raffles Medical Group first-half profit doubles on back of COVID-19 jabs, tests Toggle share menu
Advertisement
Google Street View of Raffles Hospital at North Bridge Road.
26 Jul 2021 01:20PM) Share this content
Bookmark
SINGAPORE: Raffles Medical Group more than doubled its first-half net profit thanks to sales from COVID-19 vaccinations and testing, said the group on Monday (Jul 26).
Net profit came in at S$39.4 million in the first half of 2021 versus the S$17.2 million during the same period last year.
Advertisement
Advertisement
Advertisement
Advertisement
“Adapting to the ever-changing nature of the pandemic, it has expanded its operations beyond air-border screening and pre-event testing to include vaccination centres, pre-departure swabbing of cruise passengers, as well as operating dedicated polymerase chain reaction (PCR) testing centres to conduct tests for those exposed to new COVID-19 clusters as they emerge.”